Zobrazeno 1 - 10
of 20
pro vyhledávání: '"M. A. Asnaghi"'
Autor:
M. Adelaide Asnaghi, Laura Power, Andrea Barbero, Martin Haug, Ruth Köppl, David Wendt, Ivan Martin
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
The definition of quality controls for cell therapy and engineered product manufacturing processes is critical for safe, effective, and standardized clinical implementation. Using the example context of cartilage grafts engineered from autologous nas
Externí odkaz:
https://doaj.org/article/81e17940a4d946bea057ef0d1da13bd5
Publikováno v:
European Cells & Materials, Vol 31, Pp 382-394 (2016)
Engineered tissue grafts have been manufactured using methods based predominantly on traditional labour-intensive manual benchtop techniques. These methods impart significant regulatory and economic challenges, hindering the successful translation of
Externí odkaz:
https://doaj.org/article/b6390873b674419ab4279f978bff6afb
Autor:
Gordian Born, Evelia Plantier, Guido Nannini, Alessandro Caimi, Andrea Mazzoleni, M. Adelaide Asnaghi, Manuele G. Muraro, Arnaud Scherberich, Ivan Martin, Andrés García‐García
Publikováno v:
Biotechnology journalREFERENCES.
Bioreactors enabling direct perfusion of cell suspensions or culture media through the pores of 3D scaffolds have long been used in tissue engineering to improve cell seeding efficiency as well as uniformity of cell distribution and tissue developmen
Autor:
Patrik Önnerfjord, Alejandro Garcia Garcia, Ivan Martin, Boris Dasen, Pilar Lorenzo, Fabiana Gullotta, Thibaut Klein, Magnus Tägil, Attilio Bondanza, Loraine Kouba, Deepak Bushan Raina, Paul Bourgine, Steven J. Dupard, Miriam Filippi, Claude Jaquiery, Sebastien Pigeot, M. Adelaide Asnaghi, Andrés García-García, Hanna Isaksson, Sujeethkumar Prithiviraj
Publikováno v:
Advanced materials (Deerfield Beach, Fla.). 33(43)
Design criteria for tissue-engineered materials in regenerative medicine include robust biological effectiveness, off-the-shelf availability, and scalable manufacturing under standardized conditions. For bone repair, existing strategies rely on prima
The definition of quality controls for cell therapy and engineered product manufacturing processes is critical for safe, effective, and standardized clinical implementation. Using the example context of cartilage grafts engineered from autologous nas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b14d7725478fc97013e59c484986ae16
https://doi.org/10.1101/2020.02.12.945527
https://doi.org/10.1101/2020.02.12.945527
Autor:
David Wendt, Andrea Barbero, Ivan Martin, M. Adelaide Asnaghi, Laura Power, Anke Wixmerten, Claudia Fasolato
Publikováno v:
Biosensors and Bioelectronics
Nasal chondrocyte-derived engineered cartilage has been demonstrated to be safe and feasible for the treatment of focal cartilage lesions with promising preliminary evidences of efficacy. To ensure the quality of the products and processes, and to me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b33868723a4111e9f0b0950b424522
http://hdl.handle.net/11391/1478389
http://hdl.handle.net/11391/1478389
Autor:
Helen L. Quasnichka, David Wendt, Ralph Duhr, Ivan Martin, M. Adelaide Asnaghi, Wael Kafienah, Anthony P. Hollander
Publikováno v:
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Asnaghi, M A, Duhr, R, Quasnichka, H, Hollander, A, Martin, I, Kafienah, W & Wendt, D 2018, ' Chondrogenic differentiation of human chondrocytes cultured in the absence of ascorbic acid ', Journal of Tissue Engineering and Regenerative Medicine, vol. 12, no. 6 . https://doi.org/10.1002/term.2671
Asnaghi, M A, Duhr, R, Quasnichka, H, Hollander, A, Martin, I, Kafienah, W & Wendt, D 2018, ' Chondrogenic differentiation of human chondrocytes cultured in the absence of ascorbic acid ', Journal of Tissue Engineering and Regenerative Medicine, vol. 12, no. 6 . https://doi.org/10.1002/term.2671
Bioreactor systems will likely play a key role in establishing regulatory compliant and cost-effective production systems for manufacturing engineered tissue grafts for clinical applications. However, the automation of bioreactor systems could become
Publikováno v:
Journal of Tissue Engineering and Regenerative Medicine. 12:e42-e52
Cardiovascular diseases represent a major global health burden, with high rates of mortality and morbidity. Autologous grafts are commonly used to replace damaged or failing blood vessels; however, such approaches are hampered by the scarcity of suit
Autor:
Filippo Ballo, Silvia Maestroni, M. Adelaide Asnaghi, Sara Mantero, Alessandro Filippo Pellegata, Gianpaolo Zerbini, Tommaso Dominioni, Sandro Zonta
Publikováno v:
Cells Tissues Organs. 200:363-373
There is still an unmet clinical need for small-caliber artery substitution. Decellularized scaffolds in tissue engineering represent a promising solution. We have developed an innovative system for the automatic decellularization of blood vessels, u
Autor:
Eric T. Everett, Satz Mengensatzproduktion, Zhaoyu Yin, Toshihiko Iwanaga, Pello Sánchez, Jeremy K. Brown, Alessandro Filippo Pellegata, W. Colin Duncan, Eva Rubio-Azpeitia, Diego Delgado, Sandro Zonta, Ryosuke Nakamura, Lu Liu, Filippo Ballo, Gianpaolo Zerbini, Jian Li, E. Angeles Martinez-Mier, John S. Preisser, Werner Druck Medien Ag, Fumio Nakamura, Junko Nio-Kobayashi, M. Adelaide Asnaghi, Tommaso Dominioni, Chaitanya P. Puranik, Ying Zhang, Andrew W Horne, Silvia Maestroni, Sara Mantero, Isabel Andia, Shuang Lei, Shigeharu Fukunaga, Kathleen A. Ryan, Kaiqiang Zhang, Hazirah B. Z. Abidin
Publikováno v:
Cells Tissues Organs. 200